Department of Nuclear Medicine, University Hospital and University Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Int J Cardiovasc Imaging. 2020 Apr;36(4):713-722. doi: 10.1007/s10554-019-01750-2. Epub 2020 Jan 1.
Coronary computed tomography angiography (CCTA) provides critical prognostic information on plaque burden and stenosis severity of coronary arteries. We aimed to investigate the long-term prognostic value of coronary artery volume per myocardial mass as a potential new imaging parameter. Consecutive patients with suspected coronary artery disease (CAD) were included. Coronary artery volume index (CAVi) was defined as volume over myocardial mass. Additionally, obstructive CAD (≥ 70% stenosis) and segment severity score (SSS: sum of all segments scored according to lesion severity with 0 = no lesion, 1 = narrowing < 50%, 2 = stenosis 50-69% and 3 = stenosis ≥ 70%) were evaluated. Major adverse cardiovascular events (MACE) were defined as cardiac death, non-fatal myocardial infarction or revascularization. The association of CAVi with MACE was evaluated using Cox regression hazards ratios (HR) and Kaplan Meier curves. In a total of 325 patients, 36 (11.1%) patients experienced MACE during the mean follow-up of 5.4 ± 1.7 years. Patients with low-CAVi (< 27.9 mm/g) experienced more MACE than patients with high-CAVI (17.2% versus 4.5%, p < 0.001, Kaplan Meier curve p = 0.001). SSS, obstructive CAD and low-CAVi were all significant predictors of MACE in univariable analysis (HR 1.14, 95% CI 1.09-1.19, p < 0.001; HR 5.51, 95% CI 2.86-10.60, p < 0.001; and HR 3.79, 95% CI 1.66-8.65, p = 0.002, respectively). CAVi maintained significant association with MACE when adjusted to SSS (CAVi HR 2.43, 95% CI 1.02-5.75, p = 0.04) or obstructive CAD (CAVi HR 2.4, 95% CI 1.002-5.75, p = 0.049). CAVi could further risk stratify patients without obstructive CAD when stratifying patients according to obstructive CAD (Kaplan-Meier curve p = 0.049). CAVi is a novel CCTA-derived imaging parameter, yielding independent prognostic value over stenosis and plaque burden.
冠状动脉计算机断层扫描血管造影(CCTA)提供了关于冠状动脉斑块负担和狭窄严重程度的关键预后信息。我们旨在研究冠状动脉容积与心肌质量比(CAVi)作为一种新的潜在影像学参数的长期预后价值。连续纳入疑似冠心病(CAD)的患者。冠状动脉容积指数(CAVi)定义为容积与心肌质量的比值。此外,还评估了阻塞性 CAD(≥70%狭窄)和节段严重程度评分(SSS:根据病变严重程度对所有节段进行评分的总和,0=无病变,1=狭窄<50%,2=狭窄 50-69%,3=狭窄≥70%)。主要不良心血管事件(MACE)定义为心脏死亡、非致死性心肌梗死或血运重建。使用 Cox 回归风险比(HR)和 Kaplan-Meier 曲线评估 CAVi 与 MACE 的关系。在 325 例患者中,36 例(11.1%)患者在平均 5.4±1.7 年的随访中发生 MACE。低 CAVi(<27.9mm/g)患者发生 MACE 的比例高于高 CAVi 患者(17.2%比 4.5%,p<0.001,Kaplan-Meier 曲线 p=0.001)。在单变量分析中,SSS、阻塞性 CAD 和低 CAVi 均为 MACE 的显著预测因素(HR 1.14,95%CI 1.09-1.19,p<0.001;HR 5.51,95%CI 2.86-10.60,p<0.001;HR 3.79,95%CI 1.66-8.65,p=0.002)。在校正 SSS(CAVi HR 2.43,95%CI 1.02-5.75,p=0.04)或阻塞性 CAD(CAVi HR 2.4,95%CI 1.002-5.75,p=0.049)后,CAVi 与 MACE 仍存在显著相关性。当根据阻塞性 CAD 对患者进行分层时,CAVi 可进一步对无阻塞性 CAD 的患者进行危险分层(Kaplan-Meier 曲线 p=0.049)。CAVi 是一种新的 CCTA 衍生的影像学参数,在狭窄和斑块负担方面提供了独立的预后价值。